APA (7th ed.) Citation

Hetland, M., Østergaard, M., Stengaard-Pedersen, K., Junker, P., Ejbjerg, B., Jacobsen, S., . . . Krogh, N. S. (2019). Anti-cyclic citrullinated peptide antibodies, 28-joint Disease Activity Score, and magnetic resonance imaging bone oedema at baseline predict 11 years' functional and radiographic outcome in early rheumatoid arthritis. Scandinavian Journal of Rheumatology, 48(1), 1. https://doi.org/10.1080/03009742.2018.1466362

Chicago Style (17th ed.) Citation

Hetland, ML, et al. "Anti-cyclic Citrullinated Peptide Antibodies, 28-joint Disease Activity Score, and Magnetic Resonance Imaging Bone Oedema at Baseline Predict 11 Years' Functional and Radiographic Outcome in Early Rheumatoid Arthritis." Scandinavian Journal of Rheumatology 48, no. 1 (2019): 1. https://doi.org/10.1080/03009742.2018.1466362.

MLA (9th ed.) Citation

Hetland, ML, et al. "Anti-cyclic Citrullinated Peptide Antibodies, 28-joint Disease Activity Score, and Magnetic Resonance Imaging Bone Oedema at Baseline Predict 11 Years' Functional and Radiographic Outcome in Early Rheumatoid Arthritis." Scandinavian Journal of Rheumatology, vol. 48, no. 1, 2019, p. 1, https://doi.org/10.1080/03009742.2018.1466362.